1
|
Jiang W, Yuan Y. Current State of Consultation-Liaison Psychiatry in China and Future Directions. J Acad Consult Liaison Psychiatry 2024:S2667-2960(24)00045-4. [PMID: 38616016 DOI: 10.1016/j.jaclp.2024.04.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/04/2024] [Revised: 03/20/2024] [Accepted: 04/01/2024] [Indexed: 04/16/2024]
Abstract
This article provides an overview of the history and current status of consultation-liaison psychiatry (CLP) in China and its development within the Chinese Society of Psychosomatic Medicine. Over the past decade, various CLP practice models have been developed to meet the diverse needs of different regions in China. Notably, the Chinese Multidisciplinary Integrated Centers of Psychosomatic Medicine have been established as regional hubs throughout the country. Additionally, this article delves into the role of Chinese traditional medicine in the practice of CLP in China. Finally, several projects involving CLP-based multidisciplinary collaboration are highlighted. We hope this article offers a bird's-eye view of CLP in China and opens a window for future collaboration with CLP initiatives in other countries.
Collapse
Affiliation(s)
- Wenhao Jiang
- Department of Psychosomatics and Psychiatry, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China
| | - Yonggui Yuan
- Department of Psychosomatics and Psychiatry, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China.
| |
Collapse
|
2
|
Li S, Xue Q, Zhong Y, Liao P, Ji Q, Yang X, Feng X, Zhou L, Zhu F. Research trends in complementary and alternative treatments for insomnia over the past decade: A bibliometrics analysis. Medicine (Baltimore) 2023; 102:e34346. [PMID: 37478275 PMCID: PMC10662862 DOI: 10.1097/md.0000000000034346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/25/2023] [Accepted: 06/23/2023] [Indexed: 07/23/2023] Open
Abstract
Insomnia is the most common sleep disorder, with persistent insomnia being associated with greater risk and leading to a range of functional consequences that place a heavy burden on patients and healthcare systems. A weight of evidence has shown that complementary and alternative medicine (CAM) seems to have a positive effect on improving sleep. However, the research trends of CAM intervention for insomnia have not been studied systematically through bibliometrics. We searched the relevant literature over the past decade in the Web of Science Core Collection database on September 20, 2022 and used CiteSpace and gCLUTO to visually analyze and cluster countries, institutions, authors, journals and keywords. Through screening, 1655 papers were included. In the past decade, the number of articles published in this field shown an annual trend of growth, with explosive growth in 2020. The USA has the largest number of publications, the University of Hong Kong is the leading institution in this field, and the most cited journal is Sleep. Mental condition and quality of life in patients with insomnia, insomnia related to cancer, effect of mindfulness meditation, yoga and aromatherapy on insomnia and the psychiatric symptoms resulting from the COVID-19 pandemic are at the forefront of this field. In this study, bibliometrics and visualization analysis were performed on related studies on CAM intervention for insomnia. This will be the focus and development direction of insomnia treatment in the future to formulate structured treatment plans for traditional Chinese medicine-related CAM, validate large-scale clinical trials, solve cancer comorbidity insomnia and related psychiatric symptoms and deal with mental health-related insomnia after public health outbreaks.
Collapse
Affiliation(s)
- Siyun Li
- Acupuncture Department, Zigong First People’s Hospital, Zigong, China
- Academy of Medical Sciences, Zigong First People’s Hospital, Zigong, China
| | - Qian Xue
- Acupuncture Department, Zigong First People’s Hospital, Zigong, China
- Academy of Medical Sciences, Zigong First People’s Hospital, Zigong, China
| | - Yue Zhong
- Acupuncture Department, Zigong First People’s Hospital, Zigong, China
- Academy of Medical Sciences, Zigong First People’s Hospital, Zigong, China
| | - Pengfei Liao
- Acupuncture Department, Zigong First People’s Hospital, Zigong, China
- Academy of Medical Sciences, Zigong First People’s Hospital, Zigong, China
| | - Qiang Ji
- Acupuncture Department, Zigong First People’s Hospital, Zigong, China
- Academy of Medical Sciences, Zigong First People’s Hospital, Zigong, China
| | - Xiaoyan Yang
- Acupuncture Department, Zigong First People’s Hospital, Zigong, China
- Academy of Medical Sciences, Zigong First People’s Hospital, Zigong, China
| | - Xia Feng
- Acupuncture Department, Zigong First People’s Hospital, Zigong, China
- Academy of Medical Sciences, Zigong First People’s Hospital, Zigong, China
| | - Li Zhou
- Acupuncture Department, Zigong First People’s Hospital, Zigong, China
- Academy of Medical Sciences, Zigong First People’s Hospital, Zigong, China
| | - Fengya Zhu
- Acupuncture Department, Zigong First People’s Hospital, Zigong, China
- Academy of Medical Sciences, Zigong First People’s Hospital, Zigong, China
| |
Collapse
|
3
|
Li W, Cheng Y, Zhang Y, Qian Y, Wu M, Huang W, Yang N, Liu Y. Shumian Capsule Improves the Sleep Disorder and Mental Symptoms Through Melatonin Receptors in Sleep-Deprived Mice. Front Pharmacol 2022; 13:925828. [PMID: 35873551 PMCID: PMC9304889 DOI: 10.3389/fphar.2022.925828] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2022] [Accepted: 05/23/2022] [Indexed: 12/03/2022] Open
Abstract
Healthy sleep is vital to maintaining the body's homeostasis. With the development of modern society, sleep disorder has gradually become one of the most epidemic health problems worldwide. Shumian capsule (SMC), a kind of traditional Chinese medicine (TCM) commonly used for insomnia, exhibits antidepressant and sedative effects in clinical practice. However, the underlying mechanisms have not been fully clarified. With the aid of a network pharmacology approach and function enrichment analysis, we identified the involvement of melatonin receptors in the antidepressant and sedative effects of SMC. In sleep-deprived mice, SMC treatment significantly alleviated insomnia and relevant mental alterations by improving both sleep latency and sleep duration. However, ramelteon, a selective melatonin receptor agonist that has been approved for the treatment of insomnia, only improved sleep latency. Additionally, SMC exhibited comparable effects on mental alterations with ramelteon as determined by an open-field test (OFT) and forced swimming test (FST). Mechanistically, we revealed that the melatonin receptor MT1 and MT2 signaling pathways involved the therapeutic effects of SMC. In addition to the single effect of traditional melatonin receptor agonists on treating sleep onset insomnia, SMC had therapeutic potential for various sleep disorders, such as sleep onset insomnia and sleep maintenance insomnia. Convergingly, our findings provide theoretical support for the clinical application of SMC.
Collapse
Affiliation(s)
- Wenhua Li
- Department of Pharmacology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, China
| | - Yinlong Cheng
- Department of Pharmacology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, China
| | - Yi Zhang
- Medical College, Tibet University, Lhasa, China
| | - Yazhi Qian
- Department of Pharmacology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, China
| | - Mo Wu
- Department of Pharmacology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, China
| | - Wei Huang
- Department of Pharmacology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, China
| | - Nan Yang
- Department of Pharmacology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, China
- *Correspondence: Nan Yang, ; Yanyong Liu,
| | - Yanyong Liu
- Department of Pharmacology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, China
- Medical College, Tibet University, Lhasa, China
- *Correspondence: Nan Yang, ; Yanyong Liu,
| |
Collapse
|